Log in to your Inderes Free account to see all free content on this page.
Q-Linea
15.90 SEK
-2.75 %
Less than 1K followers
QLINEA
NASDAQ Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
-2.75 %
-33.75 %
-37.89 %
-36.25 %
-35.43 %
-55.19 %
-96.91 %
-99.92 %
-99.82 %
Q-Linea operates in the medical technology sector. The company specializes in research and development of instruments and consumables. The products are mainly used in the treatment of infectious diseases and blood poisoning, and include diagnostic and analytical tools, as well as basic sample handling. The technology is based on the so-called ID and AST technology. Q-Linea was founded in 2008 and is headquartered in Uppsala.
Read moreMarket cap
301.29M SEK
Turnover
250.9K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
27.5.
2026
General meeting '26
10.7.
2026
Interim report Q2'26
30.10.
2026
Interim report Q3'26
All
Webcasts
Press releases
ShowingAll content types
Interim report January - March 2026
NOTICE OF ANNUAL GENERAL MEETING IN Q-LINEA AB (PUBL)
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
